Weekly Spotlight - 14.11.24

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

In the News

Pulmonary Hemosiderosis in Children: A Case of Hopeful Recovery

A young girl with Down syndrome and pulmonary hemosiderosis, linked to microscopic polyangiitis, showed improvement after treatment with corticosteroids and immunosuppressants. Her condition stabilised, with no relapses, highlighting the importance of personalised, long-term care for managing complex health issues in children.

Interatrial Septum Dissection Managed with Amplatzer Device: A Case Report

An 85-year-old woman experienced a rare complication during mitral valve repair, involving interatrial septum dissection. The innovative use of an Amplatzer occluder device successfully managed the issue. Chronic steroid use may increase risk, highlighting the importance of careful monitoring and personalised treatment decisions in such procedures.

Portuguese Experts Discuss ANCA Vasculitis Treatment Challenges and Solutions

Portuguese nephrologists and rheumatologists explored the treatment of ANCA vasculitis, revealing partial adherence to European guidelines. A Delphi panel showed no consensus on treatment statements, highlighting the need for standardised practices. This study emphasises aligning national practices with European recommendations to improve patient outcomes in Portugal.

Rituximab and Cyclophosphamide Equally Effective in Childhood Vasculitis Treatment

Rituximab and cyclophosphamide are equally effective in treating childhood vasculitis, achieving similar remission rates. Rituximab requires a lower steroid dose, offering a gentler treatment option. However, it has a higher hospitalisation rate due to drug-related issues. This study aids in choosing treatments for childhood vasculitis, providing hope and guidance.